Camlin Fine Sciences Limited · NSE:CAMLINFINE
Camlin Fine Sciences — Q4 FY23 Earnings Presentation
23 slides from Camlin Fine Sciences's earnings presentation, May 22, 2023
Slide 1: Stock exchange intimation of earnings presentation
May 22, 2023 To, To, BSE Limited, Listing Department, 25, P. J. Towers, National Stock Exchange of India Ltd., Dalal Street, Exchange Plaza, Bandra Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai‐ 400051 Ref: Company Scrip Code: 532834 Ref: Symbol: CAMLINFINE || Series: EQ Sub: Intimation purs
Slide 2: Q4 FY23 - Result Presentation
Camlin Fine Sciences Ltd. Q4 FY23 - Result Presentation
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Camlin Fine Sciences Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any
Slide 4: #start your story
#start your story
Slide 5: Q4 FY23 Operational Highlights
Q4 FY23 Operational Highlights Revenue Rs. 4,267 Mn EBITDA* Rs. 557 Mn PAT Rs. 35 Mn 13.1% 0.8% Margin Operational Highlights Camlin Fine Sciences Limited • Highest ever standalone and consolidated annual turnovers • Marginal reduction in the gross margins due to pricing pressures • Highest ever ann
Slide 6: Performance Highlights
Performance Highlights Revenue (Rs. In Mn) EBITDA* (Rs. In Mn) PAT (Rs. In Mn) 6.3% 12.8% 13.1% 3.4% 5.9% 0.8% Margin Quarterly Highlights +10% 4,267 +129% -74% 3,892 3,878 Camlin Fine Sciences Limited 557 229 498 133 243 35 Q4FY22 Q3FY23 Q4FY23 Q4FY22 Q3FY23 Q4FY23 Q4 FY22 Q3 FY23 Q4 FY23 10.8% 12.
Slide 7: Operational Revenue Break-up
Operational Revenue Break-up Shelf Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf Life Solution (Rs. In Mn) +20% +22% +21% 4,576 5,103 9,679 3,812 4,168 7,980 Camlin Fine Sciences Limited +19% +10% 0% 1,056 1,058 1,086 1,291 2,141 2,349 Q4FY22 Q4FY23 FY22 FY23 Q4FY22 Q4FY23 FY22 FY23 Q4FY
Slide 8: Regional Highlights
Regional Highlights CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) +15% +10% +11% 7,894 3,533 4,883 6,855 3,198 4,395 Camlin Fine Sciences Limited +10% -24% +8% 2,014 2,182 772 849 1,343 1,015 Q4FY22 Q4FY23 FY22 FY23 Q4FY22 Q4FY23 FY22 FY23 Q4FY22 Q4FY23 FY22 FY23 CFS Brazil (Rs
Slide 9: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement Particulars (Rs. In Mn) Q4 FY23 Q4 FY22 YoY FY23 FY22 YoY Revenue from Operation 4,267.1 3,892.3 9.6% 16,815.6 14,120.9 19.1% Raw material consumption 2,109.9 2,027.7 8,132.3 7,594.9 Employee Cost 408.3 377.5 1,626.2 1,450.5 Other expenses 1,310.7 1,243.8 5,004.4
Slide 10: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement Particulars (Rs. In Mn) Q4 FY23 Q4 FY22 YoY FY23 FY22 YoY Revenue from Operation 2,181.6 2,013.9 8.3% 7,894.4 6,855.1 15.2% Raw material consumption 974.6 1,045.8 3,656.9 3,945.0 Employee Cost 165.1 132.0 597.1 528.9 Other expenses 698.9 523.2 2,364.7 1,606.4 Camli
Slide 11: Consolidated Balance Sheet
Consolidated Balance Sheet Particulars (Rs. In Mn) Mar - 23 Mar - 22 Particulars (Rs. In Mn) Mar - 23 Mar - 22 Equity Non-Current assets Equity Share Capital 157.1 157.0 Property, Plant and Equipment 7,525.2 4,818.3 Other Equity 8,036.6 7,322.4 Capital Work-In-Progress 408.4 2,147.1 Minority interes
Slide 12: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement Particulars (Rs. In mn) Mar - 23 Mar - 22 Net Profit Before Tax 803.8 939.8 Adjustments for: Non Cash Items / Other Investment or Financial Items 1,295.0 776.7 Camlin Fine Sciences Limited Operating profit before working capital changes 2,098.8 1,716.5 Changes in wor
Slide 13: #start your story
#start your story
Slide 14: Company Overview
Company Overview Camlin Fine Sciences Ltd. is a vertically integrated company, engaged in the research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. Camlin Fine Sciences Limited Preferred 2006 Leading Partner for manufacturer of Established Customised
Slide 15: Business Verticals & Industries Served
Business Verticals & Industries Served Business Mix Camlin Fine Sciences Limited › Feed & Food › Functional Foods › Pharma › Food › Personal Care & Home › Livestock Feed Industries Intermediates › Animal Nutrition End User Care › Dietary › Petrochemicals › Pet Food › Flavours & Fragrances Supplement
Slide 16: Strategically Located
Strategically Located USA Italy China Mexico Cuba India Camlin Fine Sciences Limited Dominican Republic Gautemal Singapor a Colombia e Peru Brazil Argentina Chille CFS Wanglong CFS North America CFS Dresen (Dresen Camlin Fine Sciences & ` CFS do Brasil Ltda. CFS Europe SpA Flavours (Ningbo), LLC Qui
Slide 17: Integration Chain
Integration Chain Phenol Camlin Fine Sciences Limited Hydroquinone Diphenols Catechol Manufactured In-house Performance Performance Shelf Life Solutions Chemicals Aroma Ingredients Chemicals Ascorbyl Palmitate1 TBHQ MEHQ Guaiacol Guethol Other derivatives of BHA Veratrole Vanillin HQ Other derivativ
Slide 18: Way Forward: Acceleration
Way Forward: Acceleration Acceleration Camlin Fine Sciences Limited SHELF-LIFE SOLUTIONS AROMA INGREDIENTS › Increasing focus on high margin blends › Commenced 6,000 MT Vanillin facility at and additives Dahej › Introducing new products, cross-selling › Focusing on cost efficient manufacturing of ex
Slide 19: Financial Highlights
Financial Highlights
Slide 20: Operational Revenue Break-Up
Operational Revenue Break-Up Shelf Life Extension (Rs. In Mn) Blends (Rs. In Mn) Total Shelf Life Solution (Rs. In Mn) 4,576 5,103 9,679 3,812 4,168 7,980 2,860 3,135 3,311 6,171 Camlin Fine Sciences Limited 2,381 5,516 2,248 2,608 4,856 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY
Slide 21: Regional Highlights
Regional Highlights CFS India (Rs. In Mn) CFS Mexico (Rs. In Mn) CFS Europe (Rs. In Mn) 7,894 3,533 4,883 6,855 3,198 4,395 5,798 6,000 2,571 2,735 3,762 5,481 3,296 3,091 Camlin Fine Sciences Limited 2,172 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 CFS Brazil (Rs. In
Slide 22: Historical Financial Highlights
Historical Financial Highlights Revenue (Rs. In Mn) EBITDA (Rs. In Mn) PAT (Rs. In Mn) 7.7% 12.5% 15.3% 10.8% 12.7% 0.3% 2.8% 5.5% 4.3% 2.4% Margin 16,816 2,131 654 14,121 604 1,819 11,871 Camlin Fine Sciences Limited 10,491 1,528 8,922 1,307 398 298 687 30 FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY
Slide 23: Thank You
Thank You Camlin Fine Sciences Limited Camlin Fine Sciences Ltd. CIN – L74100MH1993PLCO75361 Mr. Santosh Parab- CFO Email – santosh.parab@camlinfs.com www.camlinfs.com Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Jigar Kavaiya / Mr. Shrikant Sangani Email – jigar.kavaiya@sgapl